Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer. - Wikidata - wikimedia - TriplyDB

Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.

Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q37644824

about

Therapeutic Targeting of Autophagy Interplay between apoptosis and autophagy in colorectal cancer.Epigenetic Regulation of Autophagy: A Path to the Control of Autoimmunity

P2860

Q28078117-D31DF54E-746C-4FDB-BF13-79D459A1DE31 Q42365366-A631D4D2-BDB7-446B-BA27-63BFE0551330 Q58781739-FC20B794-3F91-4A8D-81E7-493BCC56272B

P2860

Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.

http://www.wikidata.org/entity/Q37644824

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Vorinostat and hydroxychloroqu ...... metastatic colorectal cancer.

@en

Vorinostat and hydroxychloroqu ...... metastatic colorectal cancer.

@nl

type

label

Vorinostat and hydroxychloroqu ...... metastatic colorectal cancer.

@en

Vorinostat and hydroxychloroqu ...... metastatic colorectal cancer.

@nl

prefLabel

Vorinostat and hydroxychloroqu ...... metastatic colorectal cancer.

@en

Vorinostat and hydroxychloroqu ...... metastatic colorectal cancer.

@nl

P1433

Q37644824-7CC261CA-C9A2-43B5-AFDB-496419666635

P1476

Q37644824-F03038B4-26C5-4712-B862-51FE81C12C90

P2093

Q37644824-11D789A2-B425-4A0A-B97B-9AFC1B64F7C0

Q37644824-1995190B-3090-468B-9E96-B9416CEC1313

Q37644824-8F16BBBE-A833-481A-9170-5EF04E34FB22

Q37644824-972F4E5B-C94C-4B5D-9734-5B2201E5FB9B

Q37644824-A0C8CB63-5DD1-4968-B97B-E48967BDB2C5

Q37644824-AEF954CE-B985-4736-8330-E5352301D1B6

Q37644824-DF3F6F9F-A5D7-4525-97A6-7D3F13381DA8

P2860

Q37644824-01A3BA31-B222-4357-A982-8909F4FE589C

Q37644824-10BE77EA-D6B6-4577-B671-12E19A4059E3

Q37644824-18881CFB-A6C7-42C5-86E5-561CE5CFDD9E

Q37644824-22A7777B-5836-44D4-909D-63A07D77B370

Q37644824-29CBB696-E6BD-48CA-A841-16628F0C5369

Q37644824-2AF904BF-10BE-4AA0-A199-7D6EF38A6ACB

Q37644824-2CE4F334-1B97-463E-94F1-0127547D8EB3

Q37644824-3167FAA1-F586-4182-A858-C446344F5BD8

Q37644824-33CE5AC2-9115-4134-A712-5D43EF96FCB3

Q37644824-3705DBFA-E440-4A00-AA26-3F0BA50DD78B

P304

Q37644824-D964773D-508D-4468-A54F-8E522A1F50CD

P31

Q37644824-0EDC82DA-1F7E-47B6-95C3-2BAC80D1C6A2

P356

Q37644824-9D6A3F1D-5140-410D-9ABF-87D768D86291

P407

Q37644824-033980E8-2D52-4055-BE37-A124EF29BC53

P433

Q37644824-8C83CF77-93C7-41FE-9177-AB0DB3E2128E

P478

Q37644824-4686F984-BA9C-4935-BA89-3A37EF836285

P50

Q37644824-10D55A1D-39BF-41A6-BAFA-BBF84B63C3E8

P577

Q37644824-846DCD2B-762B-4471-8D61-F8608F52D0F2

P698

Q37644824-B4B0B382-354B-4519-BFAB-1469DA602228

P921

Q37644824-BCC368E6-5C37-4712-A916-21B61E9EA6D4

Q37644824-DD480FEC-5D93-4596-A9E5-24FB38155485

Q37644824-F29FDA04-5BE5-4976-A7DC-6375AC10A34E

P932

Q37644824-A686CD83-CAEC-48D5-8BAF-21A2A36F87B7

P356

ONCOTARGET.10824

P1433

P1476

Vorinostat and hydroxychloroqu ...... n metastatic colorectal cancer

@en

P2093

Devalingam Mahalingam

http://www.w3.org/2001/XMLSchema#string

Joel Michalek

http://www.w3.org/2001/XMLSchema#string

John Sarantopoulos

http://www.w3.org/2001/XMLSchema#string

Martin Goros

http://www.w3.org/2001/XMLSchema#string

Steffan T Nawrocki

http://www.w3.org/2001/XMLSchema#string

Sukeshi Patel

http://www.w3.org/2001/XMLSchema#string

Tyler Curiel

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Decitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivo

Systematic review of microsatellite instability and colorectal cancer prognosis

Autophagy in infection, inflammation, and immunity

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.

Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.

P304

59087-59097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10824

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27463016

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

hydroxychloroquine

P932

5312297

http://www.w3.org/2001/XMLSchema#string